Bangalore, Dec 22 (UNI) The biotech industry must use open sourcing to come out with effective drugs for infectious diseases like tuberculosis, according to Council for Scientific and Industrial Research (CSIR) Director General Samir Brahmachari.
Speaking at the Bio-Spectrum Awards Nite here last night, he said academia, industry and research organisations should work together to develop drugs, which were cheap and effective.
''Thousands of poor TB patients die due to non-availability of effective drug. The industry should do something to develop the best drug to fight TB,'' he said.
''Demand the best from youth, set a high standard and then see how they achieve it'', he said.
Union Bio-Technology Secretary S Natesh said the government was ready to involve private sector in the development of bio-technology and the National Biotechnology Policy (NBTP) testified it.
''The policy advocates private participation. There is a clear and unambiguous statement on the importance of involving private sector in BT,'' he said.
He said the industry must be ready to cooperate with the government as it was ready to help the industry grow in the right direction.
''The government is ready to share the cost of product development. But the industry is not coming out with noticeable new technologies. We have done very little in terms of developing stem cell technology,'' he added.